Physician

David Alan Tack, M.D.

According to 2025 Medicare claims, David Tack, M.D. (NPI: 1124032990) practices dermatology in the Carson City, NV market, with the plurality of this provider's patient population coming from Carson City, NV. This provider's primary affiliated billing organization is CLEMMENSEN, ADAMS, & TACK PSC (NPI: 1780852368; TIN: 88-0175775) and primary practice location at 89703-4634.

Tack's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,886 traditional Medicare patients, billed 16,782 HCPCS/CPT codes, and received $922,728 in Medicare payments. The top billing code was 17110 (Destruction of skin growth, 1-14 growths). Part D data shows 812 prescription claims across 469 beneficiaries totaling $104,441 in drug costs, led by Clobetasol Propionate (Clobetasol Propionate). Open Payments data shows 35 records totaling $715. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $48,187 and ending at $104,441. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$524K$1.0M2015 Medicare payment: $814,580 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $822,966 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $827,985 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $919,164 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $966,195 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $1,047,095 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $952,671 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $923,424 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $934,189 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $922,728 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20151,83616,995$814,580
20161,80615,453$822,966
20171,81015,113$827,985
20181,88816,921$919,164
20191,87517,659$966,195
20201,83418,459$1,047,095
20211,81718,220$952,671
20221,81518,458$923,424
20231,80917,030$934,189
20241,88616,782$922,728

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$52K$104K2015 Drug cost: $48,187 (USD; Tot_Drug_Cst)2016 Drug cost: $45,107 (USD; Tot_Drug_Cst)2017 Drug cost: $33,288 (USD; Tot_Drug_Cst)2018 Drug cost: $26,357 (USD; Tot_Drug_Cst)2019 Drug cost: $66,875 (USD; Tot_Drug_Cst)2020 Drug cost: $20,615 (USD; Tot_Drug_Cst)2021 Drug cost: $14,389 (USD; Tot_Drug_Cst)2022 Drug cost: $20,499 (USD; Tot_Drug_Cst)2023 Drug cost: $23,070 (USD; Tot_Drug_Cst)2024 Drug cost: $104,441 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015270555$48,187
2016286581$45,107
2017253546$33,288
2018286503$26,357
2019254423$66,875
2020277503$20,615
2021362615$14,389
2022373585$20,499
2023433736$23,070
2024469812$104,441

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
17110Destruction of skin growth, 1-14 growths1,0491,377$79
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more1,6712,403$59
17000Destruction of precancer skin growth, 1 growth1,5112,012$31
88305Pathology examination of tissue using a microscope, intermediate complexity5951,053$28
17003Destruction of precancer skin growth, 2-14 growths1,1776,868$5

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Clobetasol PropionateClobetasol Propionate732,056$3,357
Triamcinolone AcetonideTriamcinolone Acetonide2377,361$2,098
KetoconazoleKetoconazole401,180$1,034
CephalexinCephalexin1591,191$807
MetronidazoleMetronidazole31962$719

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.35$715ABBVIE INC.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for David Alan Tack, M.D.?

Tedicare shows public-source Medicare data for David Alan Tack, M.D. (NPI 1124032990), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does David Alan Tack, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to David Alan Tack, M.D.?

David Alan Tack, M.D. is linked to CLEMMENSEN, ADAMS, & TACK PSC (billing NPI 1780852368) in the available physician profile data.

Does David Alan Tack, M.D. have Open Payments data?

David Alan Tack, M.D. has 35 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.